Arrowhead Pharmaceuticals, Inc.ARWRNASDAQ
Loading
Shares Out (Diluted) Over TimeExpanding
Percentile Rank100
3Y CAGR+8.3%
5Y CAGR+5.8%
Year-over-Year Change
Weighted average diluted shares outstanding
3Y CAGR
+8.3%/yr
vs +6.0%/yr prior
5Y CAGR
+5.8%/yr
Consistent
Acceleration
+2.3pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 133758000.00 | +11.7% |
| 2024 | 119784000.00 | +12.2% |
| 2023 | 106750000.00 | +1.3% |
| 2022 | 105426000.00 | +1.6% |
| 2021 | 103745000.00 | +3.0% |
| 2020 | 100722224.00 | +2.1% |
| 2019 | 98607815.00 | +17.9% |
| 2018 | 83638469.00 | +13.2% |
| 2017 | 73898598.00 | +21.0% |
| 2016 | 61050880.00 | - |